Perspective: What next for treatment?
- 14 September 2016
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 537 (7620), S111
- https://doi.org/10.1038/537s111a
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaThe New England Journal of Medicine, 2015
- Pazopanib versus Sunitinib in Metastatic Renal-Cell CarcinomaThe New England Journal of Medicine, 2013
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaThe New England Journal of Medicine, 2007
- Sunitinib in Patients With Metastatic Renal Cell CarcinomaJAMA, 2006